08 Jun 2020 New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis Member news
04 Jun 2020 Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis Member news
28 May 2020 Mithra signs license and supply agreement with Mayne Pharma for commercialization of Estelle in Australia Member news
26 May 2020 argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis Member news
21 May 2020 Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib Member news
20 May 2020 Mithra and Searchlight Pharma announce filing of new drug submission for Estelle® in Canada Member news
18 May 2020 Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
